subungual onychomycosis, which is the typical appearance seen in most dermatophyte infections: the disease spreads from the hyponychium into the nail and then progresses proximally, frequently along the lateral margins to affect the whole nail. Superficial white onychomycosis can be caused by a dermatophyte, usually Trichophyton mentagrophytes var. interdigitale or by nondermatophytic moulds. T...

INTRODUCTION An acute infection of the nail fold, called paronychia, is a common clinical problem. The basis for the implementation of the treatment is the result of microbiological examination. Due to the rapid and painful course of infection, usually an empirical antimicrobial treatment prior to obtaining microbiological test results is introduced. AIM The microbial analysis of acute infect...

Background: A Nail bed infection viz. also known as paronychia is very common condition found in people due to trauma, bacterial the nail. This can be treated with systemic Anti-inflammatory and anti-biotic Local anti-microbial ointment. In Ayurveda this explained Kunakha. use Leech therapy various internal medicine local application of drug formulations. Objective: a. To leech Infection b. app...

Mercury (Hg) is one of the most toxic heavy metals, and it largely used in illegal gold extraction Peru. We evaluated tolerance to Hg Paronychia microphylla Phil, Ambrosia artemisioides Willd Croton ruizianus Müll. Arg. plants, using controlled concentrations (5, 10 80 mg L-1). Two groups were identified according antioxidant enzymatic bioaccumulation response, but changes soluble protein sugg...

Background: The presented phase I, first-in-human study evaluated the tolerance, pharmacokinetics, and preliminary efficacy of larotinib mesylate in patients with advanced solid tumors. Methods: Cancer were assigned to receive at 50–400 mg dose levels until disease progression or intolerance. Dose-limiting toxicities assessed during Cycles 0 1. Pharmacokinetic evaluations performed after first ...

528 Ann Dermatol Received January 25, 2015, Revised August 20, 2015, Accepted for publication August 26, 2015 Corresponding author: Seong-Jin Kim, Department of Dermatology, Chonnam National University Hospital, 42 Jebong-ro, Dong-gu, Gwangju 61469, Korea. Tel: 82-62-220-6683, Fax: 82-62-222-4058, E-mail: seongkim@ chonnam.ac.kr This is an Open Access article distributed under the terms of the ...

OBJECTIVE To evaluate the impact and type of side-effects in patients treated with cetuximab and provide a description of the general measures and treatment. METHODS Retrospective safety study. We included all patients that received cetuximab from January to December 2009. All information was obtained from the Pharmacy and Oncology Department's Access databases and reviewed the patient's medi...